logo
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
Therapeutic outcome of 6198 interferon-naïve Egyptian patients with chronic hepatitis C: a real-life experience and lessons to be learned in DAAs’ era
Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells
Potential market size and impact of hepatitis C treatment in low- and middle-income countries
Hepatitis C virus infection: a risk factor for Parkinson's disease
The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature
Re: Wangensteen et al . of a letter on ‘Hepatitis C virus infection: a risk factor for Parkinson's disease.'
Discontinuity of care for mothers with chronic hepatitis B diagnosed during pregnancy
New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France
Making the case for looking beyond WHO estimates for the global burden of hepatitis C and B